FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Ian Chau

Research Profile

Procedures

Chemicals & Drugs

Concepts & Ideas

Disorders

Co-author Network

Publications

TOP 3
Tom Waddell; Jonathan Wadsley; Justin Waters; Andrew Wotherspoon; Ian Chau; Fareeda Coxon; Tom Crosby; David Cunningham; Stephen Falk; David Ferry; Alicia Frances; David Gonzalez; Tim Iveson; Wasat Mansoor; Gary Middleton; Clare Okines; Clare Peckitt; Claire Saffery; Sarah Slater; David Smith; Yolanda Barbachano
Epirubicin, oxaliplatin, and capecitabine with or without panitumumab for patients with previously untreated advanced oesophagogastric cancer (REAL3): a randomised, open-label phase 3 trial.
Richard A Hubner; Fiona Worsnop; David Cunningham; Ian Chau
Gemcitabine plus capecitabine in unselected patients with advanced pancreatic cancer.
Anastasia Constantinidou; David Cunningham; Aamir Khan; Satvinder S Mudan; Sheela Rao; Fatima Shurmahi; Uzma Asghar; Yolanda Barbachano; Ian Chau
Perioperative chemotherapy with or without bevacizumab in patients with metastatic colorectal cancer undergoing liver resection.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Ian Chau (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Tom Waddell; Jonathan Wadsley; Justin Waters; Andrew Wotherspoon; Ian Chau; Fareeda Coxon; Tom Crosby; David Cunningham; Stephen Falk; David Ferry; Alicia Frances; David Gonzalez; Tim Iveson; Wasat Mansoor; Gary Middleton; Clare Okines; Clare Peckitt; Claire Saffery; Sarah Slater; David Smith; Yolanda Barbachano
Epirubicin, oxaliplatin, and capecitabine with or without panitumumab for patients with previously untreated advanced oesophagogastric cancer (REAL3): a randomised, open-label phase 3 trial.
The lancet oncology 2013;14(6):481-9.
2013: Richard A Hubner; Fiona Worsnop; David Cunningham; Ian Chau
Gemcitabine plus capecitabine in unselected patients with advanced pancreatic cancer.
Pancreas 2013;42(3):511-5.
2013: Anastasia Constantinidou; David Cunningham; Aamir Khan; Satvinder S Mudan; Sheela Rao; Fatima Shurmahi; Uzma Asghar; Yolanda Barbachano; Ian Chau
Perioperative chemotherapy with or without bevacizumab in patients with metastatic colorectal cancer undergoing liver resection.
Clinical colorectal cancer 2013;12(1):15-22.
2012: Vikram K Jain; Andrew C Wotherspoon; Branislav Bystricky; Ian Chau; David Cunningham
Primary follicular lymphoma of the GI tract: an increasingly recognized entity.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012;30(36):e370-2.
2012: A Dewdney; David Cunningham; Yolanda Barbachano; Ian Chau
Correlation of bevacizumab-induced hypertension and outcome in the BOXER study, a phase II study of capecitabine, oxaliplatin (CAPOX) plus bevacizumab as peri-operative treatment in 45 patients with poor-risk colorectal liver-only metastases unsuitable for upfront resection.
British journal of cancer 2012;106(11):1718-21.
2012: Alice Dewdney; Bengt Glimelius; David Gonzalez de Castro; Jacqueline Oates; Josep Tabernero; Diana Tait; Rachel Wong; Andrew Wotherspoon; Yolanda Barbachano; Gina Brown; Jaume Capdevila; Andres Cervantes; Yu Jo Chua; David Cunningham; Ian Chau
Multicenter randomized phase II clinical trial comparing neoadjuvant oxaliplatin, capecitabine, and preoperative radiotherapy with or without cetuximab followed by total mesorectal excision in patients with high-risk rectal cancer (EXPERT-C).
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012;30(14):1620-7.
2012: N Starling; J Thomas; K Thomas; D Watkins; J Webb; Yolanda Barbachano; G Brown; Ian Chau; E A Hawkes; J Oates; D Cunningham
A dose escalation study of gemcitabine plus oxaliplatin in combination with imatinib for gemcitabine-refractory advanced pancreatic adenocarcinoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2012;23(4):942-7.
2012: Eliza A Hawkes; George Ladas; Andrew G Nicholson; Sheela Rao; Gihan Ratnayake; Katharina Wassilew; Yolanda Barbachano; David Cunningham; Ian Chau
Peri-operative chemotherapy in the management of resectable colorectal cancer pulmonary metastases.
BMC cancer 2012;12():326.
2012: Vikram K Jain; David Cunningham; Ian Chau
Preoperative and postoperative chemotherapy for gastric cancer.
Surgical oncology clinics of North America 2012;21(1):99-112.
2011: Jessica Evans; Kjell Pennert; Ian Swift; Diana Tait; Paris Tekkis; Andrew Wotherspoon; Ian Chau; David Cunningham; Gina Brown
Timing of surgery following preoperative therapy in rectal cancer: the need for a prospective randomized trial?
Diseases of the colon and rectum 2011;54(10):1251-9.
2011: Dorothy M Gujral; Maria Hawkins; Barbara Grilli Leonulli; Susan Ashley; Ian Chau; David Cunningham; Diana Tait
Nonsurgical management of esophageal adenocarcinoma.
Clinical colorectal cancer 2011;10(3):165-70.
2011: R Wong; A Wotherspoon; Yolanda Barbachano; G Brown; Y J Chua; S Compton; David Cunningham; T Hickish; A Khan; Satvinder S Mudan; C Saffery; A S Strimpakos; J Thomas; J Valle; Ian Chau
A multicentre study of capecitabine, oxaliplatin plus bevacizumab as perioperative treatment of patients with poor-risk colorectal liver-only metastases not selected for upfront resection.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2011;22(9):2042-8.
2011: Eliza A Hawkes; Diana Tait; Gina Brown; David Cunningham; Ian Chau
Neoadjuvant chemotherapy alone for early-stage rectal cancer: an evolving paradigm?
Seminars in radiation oncology 2011;21(3):196-202.
2011: Eliza Hawkes; Alicia F C Okines; Demetris Papamichael; Sheela Rao; Sue Ashley; Haris Charalambous; Alona Koukouma; Ian Chau; David Cunningham
Docetaxel and irinotecan as second-line therapy for advanced oesophagogastric cancer.
European journal of cancer (Oxford, England : 1990) 2011;47(8):1146-51.
2011: R Baird; A Biondo; V Chhaya; J McLachlan; A Karpathakis; S Rahman; Yolanda Barbachano; David Cunningham; Ian Chau
Toxicity associated with capecitabine plus oxaliplatin in colorectal cancer before and after an institutional policy of capecitabine dose reduction.
British journal of cancer 2011;104(1):43-50.
2011: Branislav Bystricky; Ian Chau
Patupilone in cancer treatment.
Expert opinion on investigational drugs 2011;20(1):107-17.
2010: Alicia Fc Okines; Alice Dewdney; Ian Chau; Sheela Rao; David Cunningham
Trastuzumab for gastric cancer treatment.
Lancet 2010;376(9754):1736; author reply 1736-7.
2010: Alicia F C Okines; SE Ashley; David Cunningham; Jacqui Oates; Andrea Turner; Janine Webb; Claire Saffery; Yu Jo Chua; Ian Chau
Epirubicin, oxaliplatin, and capecitabine with or without panitumumab for advanced esophagogastric cancer: dose-finding study for the prospective multicenter, randomized, phase II/III REAL-3 trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(25):3945-50.
2010: A S Strimpakos; David Cunningham; C Mikropoulos; I Petkar; Yolanda Barbachano; Ian Chau
The impact of carcinoembryonic antigen flare in patients with advanced colorectal cancer receiving first-line chemotherapy.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2010;21(5):1013-9.
2010: Yu Jo Chua; Yolanda Barbachano; David Cunningham; Jacqui R Oates; Gina Brown; Andrew Wotherspoon; Diana Tait; Alison Massey; Niall C Tebbutt; Ian Chau
Neoadjuvant capecitabine and oxaliplatin before chemoradiotherapy and total mesorectal excision in MRI-defined poor-risk rectal cancer: a phase 2 trial.
The lancet oncology 2010;11(3):241-8.
2010: D J Watkins; Ian Chau; David Cunningham; Satvinder S Mudan; N Karanjia; Gina Brown; Sue Ashley; Andrew R Norman; A Gillbanks
Defining patient outcomes in stage IV colorectal cancer: a prospective study with baseline stratification according to disease resectability status.
British journal of cancer 2010;102(2):255-61.
2010: A F C Okines; U Asghar; David Cunningham; Sue Ashley; J Ashton; K Jackson; E Hawkes; Ian Chau
Rechallenge with platinum plus fluoropyrimidine +/- epirubicin in patients with oesophagogastric cancer.
Oncology 2010;79(1-2):150-8.
2009: Naureen Starling; David Watkins; David Cunningham; Janet Thomas; Janine Webb; Gina Brown; Karen Thomas; Jacqui Oates; Ian Chau
Dose finding and early efficacy study of gemcitabine plus capecitabine in combination with bevacizumab plus erlotinib in advanced pancreatic cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(33):5499-505.
2009: Eliza Hawkes; Ian Chau; David H Ilson; David Cunningham
Upper gastrointestinal malignancies: a new era in clinical colorectal cancer.
Clinical colorectal cancer 2009;8(4):185-9.
2009: Ian Chau; David Cunningham
Treatment in advanced colorectal cancer: what, when and how?
British journal of cancer 2009;100(11):1704-19.
2009: N Starling; A Okines; David Cunningham; William H Allum; Andrew Wotherspoon; M Benson; J Thompson; J Thomas; Gina Brown; A Riddell; F Stavridi; Sue Ashley; Jacqui Oates; Ian Chau
A phase II trial of preoperative chemotherapy with epirubicin, cisplatin and capecitabine for patients with localised gastro-oesophageal junctional adenocarcinoma.
British journal of cancer 2009;100(11):1725-30.
2009: Ian Chau; Andrew R Norman; David Cunningham; Jacqui Oates; R Hawkins; Tim Iveson; Marianne Nicolson; P Harper; Matt Seymour; Tamas Hickish
The impact of primary tumour origins in patients with advanced oesophageal, oesophago-gastric junction and gastric adenocarcinoma--individual patient data from 1775 patients in four randomised controlled trials.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2009;20(5):885-91.
2009: Thomas Yau; David Watkins; David Cunningham; Yolanda Barbachano; Ian Chau; Geoffrey Chong
Longitudinal assessment of quality of life in rectal cancer patients with or without stomas following primary resection.
Diseases of the colon and rectum 2009;52(4):669-77.
2009: Madeleine Hewish; Ian Chau; David Cunningham
Insulin-like growth factor 1 receptor targeted therapeutics: novel compounds and novel treatment strategies for cancer medicine.
Recent patents on anti-cancer drug discovery 2009;4(1):54-72.
2008: Alicia Okines; Ian Chau; David Cunningham
Capecitabine in gastric cancer.
Drugs of today (Barcelona, Spain : 1998) 2008;44(8):629-40.
2007: Bhawna Sirohi; David Cunningham; Andy Norman; Kim Last; Ian Chau; Alan Horwich; Jacqui Oates; Geoffrey Chong; Andrew Wotherspoon
Gemcitabine, cisplatin and methylprednisolone (GEM-P) with or without Rituximab in relapsed and refractory patients with diffuse large B cell lymphoma (DLBCL).
Hematology (Amsterdam, Netherlands) 2007;12(2):149-53.
2007: Ian Chau; David Cunningham; Tamas Hickish; Alison Massey; L Higgins; R Osborne; N Botwood; A Swaisland
Gefitinib and irinotecan in patients with fluoropyrimidine-refractory, irinotecan-naive advanced colorectal cancer: a phase I-II study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2007;18(4):730-7.
2007: Hendrik-Tobias Arkenau; Claire Gordon; David Cunningham; Andy Norman; Andrew Wotherspoon; Ian Chau
Mucosa associated lymphoid tissue lymphoma of the lung: the Royal Marsden Hospital experience.
Leukemia & lymphoma 2007;48(3):547-50.
2007: Hendrik-Tobias Arkenau; Geoff Chong; David Cunningham; David Watkins; Bhawna Sirohi; Ian Chau; Andrew Wotherspoon; Andy Norman; Alan Horwich; Estella Matutes
Gemcitabine, cisplatin and methylprednisolone for the treatment of patients with peripheral T-cell lymphoma: the Royal Marsden Hospital experience.
Haematologica 2007;92(2):271-2.
2006: Ian Chau; David Cunningham
Adjuvant therapy in colon cancer--what, when and how?
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2006;17(9):1347-59.
2006: Ian Chau; David Cunningham; C Russell; Andrew R Norman; Tom Kurzawinski; P Harper; Phillip Harrison; Gary Middleton; F Daniels; Tamas Hickish; J Prendeville; Paul J Ross; Belinda A Theis; R Hull; M Walker; N Shankley; B Kalindjian; Gordon D Murray; A Gillbanks; James W Black
Gastrazole (JB95008), a novel CCK2/gastrin receptor antagonist, in the treatment of advanced pancreatic cancer: results from two randomised controlled trials.
British journal of cancer 2006;94(8):1107-15.
2006: Ian Chau; Gina Brown; David Cunningham; Diana Tait; Andrew Wotherspoon; Andrew R Norman; Niall Tebbutt; Mark Hill; Paul J Ross; Alison Massey; Jacqui Oates
Neoadjuvant capecitabine and oxaliplatin followed by synchronous chemoradiation and total mesorectal excision in magnetic resonance imaging-defined poor-risk rectal cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(4):668-74.
2005: Ian Chau; Andrew R Norman; David Cunningham; Tim Iveson; Mark Hill; Tamas Hickish; Fiona J Lofts; Duncan I Jodrell; Andrew Webb; Diana Tait; Paul J Ross; Pat Shellito; Jacqueline R Oates
Longitudinal quality of life and quality adjusted survival in a randomised controlled trial comparing six months of bolus fluorouracil/leucovorin vs. twelve weeks of protracted venous infusion fluorouracil as adjuvant chemotherapy for colorectal cancer.
European journal of cancer (Oxford, England : 1990) 2005;41(11):1551-9.
2005: M Ng; J Waters; David Cunningham; Ian Chau; Alan Horwich; Mark Hill; Andrew R Norman; Andrew Wotherspoon; Daniel Catovsky
Gemcitabine, cisplatin and methylprednisolone (GEM-P) is an effective salvage regimen in patients with relapsed and refractory lymphoma.
British journal of cancer 2005;92(8):1352-7.
2005: Ian Chau; Andrew R Norman; David Cunningham; Diana Tait; Paul J Ross; Tim Iveson; Mark Hill; Tamas Hickish; Fiona J Lofts; Duncan I Jodrell; Andrew Webb; Jacqueline R Oates
A randomised comparison between 6 months of bolus fluorouracil/leucovorin and 12 weeks of protracted venous infusion fluorouracil as adjuvant treatment in colorectal cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005;16(4):549-57.
2004: Ian Chau; Andrew R Norman; David Cunningham; Justin S Waters; C Topham; Gary Middleton; Mark Hill; Paul J Ross; R Katopodis; G Stewart; Jacqueline R Oates
Elderly patients with fluoropyrimidine and thymidylate synthase inhibitor-resistant advanced colorectal cancer derive similar benefit without excessive toxicity when treated with irinotecan monotherapy.
British journal of cancer 2004;91(8):1453-8.
2004: Rohit Lal; James Dickson; David Cunningham; Ian Chau; Andrew R Norman; Paul J Ross; Clare Topham; Gary Middleton; Mark Hill; Jacqui Oates
A randomized trial comparing defined-duration with continuous irinotecan until disease progression in fluoropyrimidine and thymidylate synthase inhibitor-resistant advanced colorectal cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(15):3023-31.
2004: Ian Chau; Andrew R Norman; David Cunningham; Justin S Waters; Jacqui Oates; Paul J Ross
Multivariate prognostic factor analysis in locally advanced and metastatic esophago-gastric cancer--pooled analysis from three multicenter, randomized, controlled trials using individual patient data.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(12):2395-403.
2004: Ian Chau; Mark J Allen; David Cunningham; Andrew R Norman; Gina Brown; Hugo Ford; Niall Tebbutt; Diana Tait; Mark Hill; Paul J Ross; Jacqui Oates
The value of routine serum carcino-embryonic antigen measurement and computed tomography in the surveillance of patients after adjuvant chemotherapy for colorectal cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(8):1420-9.
2004: Ian Chau; Sally Legge; Pierre Fumoleau
The vital role of education and information in patients receiving capecitabine (Xeloda).
European journal of oncology nursing : the official journal of European Oncology Nursing Society 2004;8 Suppl 1():S41-53.
2003: Cheng Yeoh; Ian Chau; David Cunningham; Andrew R Norman; Mark Hill; Paul J Ross
Impact of 5-fluorouracil rechallenge on subsequent response and survival in advanced colorectal cancer: pooled analysis from three consecutive randomized controlled trials.
Clinical colorectal cancer 2003;3(2):102-7.
2003: Ian Chau; R Jones; David Cunningham; Andrew Wotherspoon; Nick R Maisey; Andrew R Norman; PARESH JAIN; L Bishop; Alan Horwich; Daniel Catovsky
Outcome of follicular lymphoma grade 3: is anthracycline necessary as front-line therapy?
British journal of cancer 2003;89(1):36-42.
2003: A Saini; Andrew R Norman; David Cunningham; Ian Chau; Mark Hill; Diana Tait; Tamas Hickish; Tim Iveson; Fiona J Lofts; Duncan I Jodrell; Paul J Ross; Jacqui Oates
Twelve weeks of protracted venous infusion of fluorouracil (5-FU) is as effective as 6 months of bolus 5-FU and folinic acid as adjuvant treatment in colorectal cancer.
British journal of cancer 2003;88(12):1859-65.
2003: Niall Tebbutt; Andrew R Norman; David Cunningham; M Allen; Ian Chau; Jacqui Oates; Mark Hill
Analysis of the time course and prognostic factors determining toxicity due to infused fluorouracil.
British journal of cancer 2003;88(10):1510-5.
2003: Ian Chau; Samuel Chan; David Cunningham
Overview of preoperative and postoperative therapy for colorectal cancer: the European and United States perspectives.
Clinical colorectal cancer 2003;3(1):19-33.
2003: Ian Chau; M Allen; David Cunningham; Diana Tait; Gina Brown; Mark Hill; Kate Sumpter; A Rhodes; Andrew Wotherspoon; Andrew R Norman; A Hill; Alison Massey; Yvonne Prior
Neoadjuvant systemic fluorouracil and mitomycin C prior to synchronous chemoradiation is an effective strategy in locally advanced rectal cancer.
British journal of cancer 2003;88(7):1017-24.
2003: Ian Chau; Mark Harries; David Cunningham; Mark Hill; Paul J Ross; Caroline D Archer; Andrew R Norman; Andrew Wotherspoon; Dow-Mu Koh; Kairen Gill; Maggie Uzzell; Yvonne Prior; Daniel Catovsky
Gemcitabine, cisplatin and methylprednisolone chemotherapy (GEM-P) is an effective regimen in patients with poor prognostic primary progressive or multiply relapsed Hodgkin's and non-Hodgkin's lymphoma.
British journal of haematology 2003;120(6):970-7.
2003: Ian Chau; M T Kelleher; David Cunningham; Andrew R Norman; Andrew Wotherspoon; PA Trott; P Rhys-Evans; G Querci Della Rovere; Gina Brown; M Allen; Justin S Waters; S Haque; T Murray; L Bishop
Rapid access multidisciplinary lymph node diagnostic clinic: analysis of 550 patients.
British journal of cancer 2003;88(3):354-61.
2003: Ian Chau; Anne Rigg; David Cunningham
Matrix metalloproteinase inhibitors--an emphasis on gastrointestinal malignancies.
Critical reviews in oncology/hematology 2003;45(2):151-76.
2002: Ian Chau; David Cunningham
Adjuvant therapy in colon cancer: current status and future directions.
Cancer treatment reviews 2002;28(5):223-36.
2002: Ian Chau; David Watkins; David Cunningham
Gemcitabine and its combinations in the treatment of malignant lymphoma.
Clinical lymphoma 2002;3(2):97-104.
2002: Nick R Maisey; Ian Chau; David Cunningham; Andy Norman; Matt Seymour; Tamas Hickish; Tim Iveson; Mary O'Brien; Niall Tebbutt; Angela Harrington; Mark Hill
Multicenter randomized phase III trial comparing protracted venous infusion (PVI) fluorouracil (5-FU) with PVI 5-FU plus mitomycin in inoperable pancreatic cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(14):3130-6.
2002: Ian Chau; David Cunningham
Chemotherapy in colorectal cancer: new options and new challenges.
British medical bulletin 2002;64():159-80.
2001: Ian Chau; Andrew Webb; David Cunningham; Mark Hill; Sheela Rao; S Ageli; Andy Norman; K Gill; A Howard; Daniel Catovsky
An oxaliplatin-based chemotherapy in patients with relapsed or refractory intermediate and high-grade non-Hodgkin's lymphoma.
British journal of haematology 2001;115(4):786-92.
2001: Ian Chau; Andrew Webb; David Cunningham; Mark Hill; Justin S Waters; Andy Norman; Alison Massey
Oxaliplatin and protracted venous infusion of 5-fluorouracil in patients with advanced or relapsed 5-fluorouracil pretreated colorectal cancer.
British journal of cancer 2001;85(9):1258-64.